Onyx Pharmaceuticals, Inc. (ONXX) Misses Q1 EPS by 13c
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $92.91 -1.52%
EPS Growth %: +72.1%
Financial Fact:
Revenue from collaboration agreement: 70.31M
Today's EPS Names:
CSS, STV, GIGM, More
EPS Growth %: +72.1%
Financial Fact:
Revenue from collaboration agreement: 70.31M
Today's EPS Names:
CSS, STV, GIGM, More
Trade ONXX Now!
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q1 EPS of ($0.68), $0.13 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $72 million versus the consensus estimate of $69.82 million.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- TJX Cos. (TJX) Reports In-Line Q1 EPS; Guides Q2 EPS, Narrows FY14 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
